发明授权
- 专利标题： Polymorphs of sorafenib acid addition salts
- 专利标题（中）： 索拉非尼酸加成盐的多晶型物
-
申请号： US13912305申请日： 2013-06-07
-
公开(公告)号： US08614329B2公开(公告)日： 2013-12-24
- 发明人: Jagdev Singh Jaryal , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
- 申请人： Jagdev Singh Jaryal , Swargam Sathyanarayana , Rajesh Kumar Thaper , Mohan Prasad
- 申请人地址： IN New Delhi
- 专利权人： Ranbaxy Laboratories Limited
- 当前专利权人： Ranbaxy Laboratories Limited
- 当前专利权人地址： IN New Delhi
- 优先权： IN2008/DEL/2009 20090924
- 主分类号： A61K31/44
- IPC分类号： A61K31/44 ; C07D213/81
摘要：
The present invention provides amorphous and crystalline forms of acid addition salts of sorafenib, pharmaceutical compositions comprising them, and their use for the treatment of cancer. The present invention also provides processes for the preparation of acid addition salts of sorafenib.
公开/授权文献
- US20130274478A1 POLYMORPHS OF SORAFENIB ACID ADDITION SALTS 公开/授权日：2013-10-17
信息查询
